Boston, MA – GE HealthCare Technologies Inc. held its Q3 2024 Earnings Conference Call on October 30, 2024, revealing insights into their financial performance and future outlook. During the call, key executives such as Carolynne Borders, Peter Arduini, and Jay Saccaro shared important updates with investors and analysts.
Borders, the Chief Investor Relations Officer, kicked off the call by welcoming participants and introducing Arduini, the President and CEO, and Saccaro, the Vice President and CFO. The executives discussed both GAAP and non-GAAP financial results, emphasizing the importance of transparency and providing reconciliations for the measures presented.
Arduini highlighted the company’s 1% organic revenue growth in the third quarter, pointing out strong performance in the U.S. and solid growth in Pharmaceutical Diagnostics. He noted positive price and volume trends, with organic orders growing by 1%. Excluding China, reported sales growth was approximately 5%, showcasing a robust performance across different market segments.
Investors and analysts, including Robbie Marcus, Ryan Zimmerman, and Joanne Wuensch, were able to ask questions during the question-and-answer session following the executives’ presentations. The call provided valuable insights into GE HealthCare’s strategic direction and its ability to navigate challenges and capitalize on opportunities in the healthcare industry.
Overall, the Q3 2024 Earnings Conference Call offered stakeholders a comprehensive overview of GE HealthCare’s financial performance and outlook, setting the stage for informed decision-making and strategic planning moving forward. The company’s focus on innovation and growth in key markets demonstrates its commitment to delivering value to shareholders and stakeholders alike.